Welcome to the IQVIA Holdings Inc. Q3 2024 Earnings Conference Call!
Company Participants:
Kerri Joseph – Senior Vice President, Investor Relations & Treasury
Ari Bousbib – Chairman and Chief Executive Officer
Ron Bruehlman – Executive Vice President and Chief Financial Officer
Eric Sherbet – Executive Vice President and General Counsel
Mike Fedock – Senior Vice President, Financial Planning and Analysis
Gustavo Peroni – Senior Director, Investor Relations
Conference Call Participants:
Ann Hynes – Mizuho
Shlomo Rosenbaum – Stifel
Anne Samuel – JP Morgan
Luke Sergott – Barclays Bank
Justin Bowers – Deutsche Bank
David Windley – Jefferies
Elizabeth Anderson – Evercore ISI
Michael Cherny – Leerink Partners
Operator:
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Third Quarter 2024 Earnings Conference Call.
It’s always exciting to hear about the latest developments and financial updates from companies like IQVIA. As we dive into the details of their third-quarter results, we get a better understanding of their performance and trajectory in the market.
With Kerri Joseph leading the Investor Relations & Treasury team and Ari Bousbib at the helm as Chairman and CEO, IQVIA is in good hands. The Executive team, including Ron Bruehlman, Eric Sherbet, and Mike Fedock, brings a wealth of experience and expertise to the table, ensuring that the company is on track to meet its financial goals.
As we listen to the insights shared by Gustavo Peroni and the conference call participants, such as Ann Hynes, Shlomo Rosenbaum, and Luke Sergott, we gain valuable perspectives on IQVIA’s standing in the industry and its potential for growth.
How Will This Affect Me?
As an investor or someone interested in the pharmaceutical and healthcare industry, the updates from IQVIA’s Q3 2024 Earnings Conference Call can provide valuable information for making informed decisions about your investments. Understanding the company’s financial performance and strategic direction can help you assess the opportunities and risks associated with IQVIA stock.
How Will This Affect the World?
IQVIA plays a critical role in advancing healthcare and pharmaceutical research globally. Their innovative solutions and data analytics drive decision-making in the industry, ultimately impacting the development of new treatments and healthcare outcomes worldwide. By staying informed on IQVIA’s performance, stakeholders can gauge the company’s influence on shaping the future of healthcare.
Conclusion:
Overall, the IQVIA Holdings Inc. Q3 2024 Earnings Conference Call offers a glimpse into the company’s financial health and strategic direction. With a strong leadership team and industry expertise, IQVIA is poised for continued success in driving innovation and progress in the healthcare sector. Investors and industry observers alike can gain valuable insights from these updates to guide their decisions and understand the broader impact of IQVIA’s work on the world.
